BTOG 2019 | MR Linac: benefits, usage & research collaborations

Fiona McDonald

The MR Linac is an exciting new development in the field of radiotherapy. Here, Fiona McDonald, MA, MBBS, MRCP, FRCR, MD, of the Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK, discusses it’s benefits, current usage in the UK and research collaborations with centers abroad. This interview took place at the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland.

Share this video